Yocca Frank bought BTAI
May 1, 2026 · Form 4 insider transaction
Yocca Frank bought 9,000 shares of BioXcel Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,000
Price
N/A
Total value
N/A
InsiderYocca Frank
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 1, 2026
Filing dateMay 7, 2026
Shares owned after15,520
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.